Aier Eye Hospital Group stock
Price history
−24.85% over the period1 year: from ¥11.91 (November 20, 2025) to ¥8.95 (November 20, 2026), −24.85%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | ¥8.95 |
| October 30, 2026 | ¥8.52 |
| September 30, 2026 | ¥7.98 |
| August 31, 2026 | ¥8.21 |
| July 31, 2026 | ¥9.08 |
| June 30, 2026 | ¥8.26 |
| May 29, 2026 | ¥9.12 |
| April 30, 2026 | ¥10.78 |
| March 31, 2026 | ¥9.51 |
| February 27, 2026 | ¥10.60 |
| January 30, 2026 | ¥11.07 |
| December 31, 2025 | ¥10.98 |
| November 28, 2025 | ¥11.50 |
| November 20, 2025 | ¥11.91 |
At a glance
The company
Operates ophthalmic hospitals and clinics offering eye disease diagnosis, treatment, surgery and optometry services
Latest results
Quarter to September 30, 2026 · EPS ¥0.10 (estimate ¥0.13)
Next event
TickerLandia's take on Aier Eye Hospital Group
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 26 vs a median of 63 over its last 10 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 34 vs 26 (+31%) in a group of 11.
- Strong point: Financial strength (85/100 in its group). Weak point: Earnings stability (38/100).
- “Below historical valuation” (China): No. 6 of 52.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−26.34% from the 52-week high
Analysts · 15 analysts
Average target¥12.03+34.38% vs. price
Buy 13 · Hold 1 · Sell 1 · Buy
TickerLandia Fingerprint: Aier Eye Hospital Group
Compared with similar companies: very high financial strength.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Pricehigh64
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 20.1 64 P/E (trailing 12 months) 34.4 69 EV/EBITDA 14.4 66 Price/book 3.69 50 Price/sales 3.58 71 Profitabilityhigh71
How much it earns on revenue and capital.
Metric Value Position in group ROE 11.0% 36 ROA 8.7% 71 Gross margin 45.4% 87 Operating margin 21.8% 92 Net margin 10.4% 71 Earnings stabilitylow38
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.6% 18 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 58 Growthaverage48
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) −12.60% 24 Average revenue growth (3 years) +11.54% 61 Revenue growth (year over year) +7.10% 61 Financial strengthvery high85
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 1.40 71 Net debt/EBITDAcounts in reverse: lower means more financial strength 0.07 97 Interest coverage 17.4 87 Debt/equitycounts in reverse: lower means more financial strength 0.32 86 Dividendhigh67
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 17 years 67 Dividend yield 2.0% 62 Payout ratio 69.2% 74 Market momentumweak39
How the stock has moved compared with the market.
Metric Value Position in group 1-year return −24.85% 17 Distance from 200-day average −2.55% 60 Risklow32
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 34.8% 52 Volatility (60 days) 22.2% 12
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Aier Eye Hospital Group is cheaper than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Aier Eye Hospital Group's P/E today is 25.6, below the median of its last 10 fiscal years (63.0; between 31.4 and 177.0 from 2016 to 2025). Aier Eye Hospital Group's P/E (trailing 12 months): 34.4, +31% against the median of a group of 11 similar companies (26.2).
Compared with 11 similar companies
| Metric | Aier Eye Hospital Group | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 34.4 | Middle | |
| Forward P/E | 20.1 | Middle | |
| Operating margin | 21.8% | High | |
| ROE | 11.0% | Middle | |
| Debt/equity | 0.32 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Aier Eye Hospital Group. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥6.4B
Latest quarter · Q3 2026
Net income
¥940.7M
Latest quarter · Q3 2026
Quarterly net margin
14.7%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ¥83.06B
- P/E
- 34.4
- EPS
- ¥0.26
- Volume
- 71.08M
- Daily trading
- €112.13M
- Dividend yield
- 2.01%
- Last ex-dividend on July 17, 2026
How Aier Eye Hospital Group is changing
All resultsRevenue grew 13.4% a year on average over the last 5 years
Operating margin fell from 24.1% to 21.0%
Profits turn into cash: free cash flow equal to 112% of net income
Returns
Aier Eye Hospital Group returns with dividends
¥1,000 invested in Aier Eye Hospital Group 5 years ago, on November 22, 2021, would be worth ¥338 today with dividends reinvested: −66.17% in total, −19.51% per year. On price alone it would be ¥321 (−67.90%).
| Period | Aier Eye Hospital Group | ¥1,000 becomes |
|---|---|---|
| 1 month | +12.72% | ¥1,127 |
| 6 months | −5.49% | ¥945 |
| Year to date | −18.49% | ¥815 |
| 1 year | −23.47% | ¥765 |
| 3 years | −46.90% | ¥531 |
| 5 years | −66.17% | ¥338 |
| 10 years | +144.86% | ¥2,449 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Aier Eye Hospital Group: technical analysis
Aier Eye Hospital Group shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 78.8% below its all-time closing high (¥42.20, July 1, 2021).
- Trend
- No clear trend
- RSI (14 sessions)
- 61
- Between 30 and 70
- vs 200-session average
- −2.55%
Active signals
The last session opened more than 3% below the previous close.
Support and resistance
Price areas where Aier Eye Hospital Group has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance¥10.37+15.81%2 touches, last on March 17, 2026
- Resistance¥9.37+4.74%5 touches, last on August 10, 2026
- Resistance¥9.14+2.16%3 touches, last on November 6, 2026
- Last price¥8.95
- Support¥8.65−3.35%2 touches, last on August 6, 2026
- Support¥8.46−5.44%3 touches, last on November 12, 2026
- Support¥8.13−9.21%5 touches, last on September 22, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 22.2%
- Largest fall in the last year
- −34.76%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Aier Eye Hospital Group: seasonality
Average monthly price change over 17 years
Over the last 17 years, the strongest month for Aier Eye Hospital Group has been February: +6.27% on average, positive in 12 years out of 17. The weakest has been August: −2.63% on average, positive in 7 years out of 17. November, the current month, has been positive in 7 years out of 17 (−0.23% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −2.62% | +0.82% | 9 of 17 |
| February | +6.27% | +3.77% | 12 of 17 |
| March | −1.45% | −4.79% | 5 of 17 |
| April | +6.23% | +6.09% | 12 of 17 |
| May | +3.59% | +3.65% | 11 of 17 |
| June | +1.62% | +0.56% | 10 of 17 |
| July | +1.75% | +2.96% | 10 of 17 |
| August | −2.63% | −3.19% | 7 of 17 |
| September | +4.51% | −0.91% | 7 of 17 |
| October | +3.20% | +1.89% | 9 of 17 |
| November | −0.23% | −1.15% | 7 of 17 |
| December | +0.48% | −0.94% | 5 of 17 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Aier Eye Hospital Group and its competitors
With 42,817 employees and a network of eye hospitals spanning China, Hong Kong, Europe, the United States and Southeast Asia, the group provides examination and treatment for a wide range of eye conditions. Its services cover fundus disease, glaucoma and cataract, with lens fitting, surgical and medical optometry, and training in cataract surgery, ICL surgery and presbyopia surgery. Patients across these regions are the main users of these services.
- Headquarters
- Changsha, China
- Employees
- 42,817
- Founded
- 2002
- Chief executive
- Li Li
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Aier Eye Hospital Group300015 | $12.44B | 21.8% | 34.4 | −5.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | $14.27B | 12.1% | 58.8 | +13.88% |
| Max Healthcare InstituteMAXHEALTH | $9.95B | 21.4% | 67.0 | +0.49% |
| Ramsay Health CareRHC | $8.37B | 5.9% | 40.0 | +40.77% |
| Fortis HealthcareFORTIS | $6.47B | 17.1% | 56.8 | −15.35% |
| Rede D'Or Sao LuizRDOR3 | $13.11B | 20.2% | 16.9 | +5.40% |
Same industry or related industries, similar size. Compare Aier Eye Hospital Group with its competitors · Full profile
